Canine babesiosis in Europe: How many diseases?

Trends in Parasitology

Volumn 28, Issue 3, 2012, Pages 99-105

  Matijatko, Vesna ^a   Torti, Marin ^a   Schetters, Theo P ^b  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b NV ORGANON   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; MALONALDEHYDE;

ADULT RESPIRATORY DISTRESS SYNDROME; ANEMIA; ANOREXIA; ANTIGENIC VARIATION; AUSTRIA; BABESIOSIS; CROATIA; DEPRESSION; FEVER; FRANCE; GENETIC VARIABILITY; GERMANY; HUNGARY; HYPOTENSION; INFLAMMATION; ITALY; LIPID PEROXIDATION; MICROBIAL DIVERSITY; MULTIPLE ORGAN FAILURE; NETHERLANDS; NONHUMAN; NORWAY; OXIDATIVE STRESS; OXYGENATION; PALLOR; PARASITE VIRULENCE; PATHOPHYSIOLOGY; POLAND; PORTUGAL; REVIEW; SLOVENIA; SPAIN; SPLENOMEGALY; SWITZERLAND; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ANIMALS; ANTIGENS, PROTOZOAN; BABESIA; BABESIOSIS; DOG DISEASES; DOGS; EUROPE;

BABESIA; BABESIA CANIS; CANIS FAMILIARIS; IXODIDA; PROTOZOA;

EID: 84857235017     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2011.11.003     Document Type: Review

References (100)

1. Kuttler K.L. World-wide impact of babesiosis. Babesiosis of Domestic Animals and Man 1988, 1-22. CRC Press. M. Ristic (Ed.).
2. Schetters T. Vaccines against canine babesiosis. Trends Parasitol. 2005, 21:179-184.
3. Birkenheuer A.J., et al. Detection and molecular characterization of a novel large Babesia species in a dog. Vet. Parasitol. 2004, 124:151-160.
4. Lehtinen L.E., et al. In vitro cultivation of a newly recognised Babesia sp. in dogs in North Carolina. Vet. Parasitol. 2008, 151:150-157.
5. Zahler M., et al. Characteristic genotypes discriminate between Babesia canis isolates of differing vector specificity and pathogenicity to dogs. Parasitol. Res. 1998, 84:544-548.
6. Carret C., et al. Babesia canis canis, Babesia canis vogeli, Babesia canis rossi: differentiation of the three subspecies by a restriction fragment length polymorphism analysis on amplified small subunit ribosomal RNA genes. J. Eukaryot. Microbiol. 1999, 46:293-303.
7. Uilenberg G. Babesia - a historical overview. Vet. Parasitol. 2006, 138:3-10.
8. Hinaidy H.K., Tschepper P. Babesia canis bei einem Hund in össtereich. Wien. Tierärztl. Mschr. 1979, 66:302-304.
9. Beck R., et al. Diversity of Babesia and Theileria species in symptomatic and asymptomatic dogs in Croatia. Int. J. Parasitol. 2009, 39:843-848.
10. Brkljačić M., et al. Molecular evidence of natural infection with Babesia canis canis in Croatia. Acta Vet. Hung. 2010, 58:39-46.
11. Bourdoiseau G. Canine babesiosis in France. Vet. Parasitol. 2006, 138:118-125.
12. Gothe R., et al. Zur Epidemiologie von Babesia canis- und Babesia gibsoni-Infektionen bei Hunden in Deutschland. Kleintierpraxis 1989, 34:309-320.
13. Földvári G., et al. Babesia canis canis in dogs from Hungary: detection by PCR and sequencing. Vet. Parasitol. 2005, 127:221-226.
14. Solano-Gallego L., et al. Babesia canis canis and Babesia canis vogeli clinicopathological findings and DNA detection by means of PCR-RFLP in blood from Italian dogs suspected of tick-borne disease. Vet. Parasitol. 2008, 157:211-221.
15. Matjila T.P., et al. Autochthonous canine babesiosis in The Netherlands. Vet. Parasitol. 2005, 131:23-29.
16. Adaszek L., Winiarczyk S. Molecular characterization of Babesia canis canis isolates from naturally infected dogs in Poland. Vet. Parasitol. 2008, 152:235-241.
17. Cardoso L., et al. Babesia canis canis and Babesia canis vogeli infections in dogs from northern Portugal. Vet. Parasitol. 2007, 156:199-204.
18. Duh D., et al. Canine babesiosis in Slovenia: molecular evidence of Babesia canis canis and Babesia canis vogeli. Vet. Res. 2004, 35:363-368.
19. Criado-Fornelio A., et al. Molecular studies on Babesia, Theileria and Hepatozoon in Southern Europe Part I. Epizootiological aspects. Vet. Parasitol. 2003, 113:189-201.
20. Sager H., et al. Autochtonous case of canine babesiosis in the canton Solothurn. Schweiz. Arch. Tierheilkd. 2005, 147:259-265.
21. Øines Ø., et al. First case of babesiosis caused by Babesia canis canis in a dog from Norway. Vet. Parasitol. 2010, 171:350-353.
22. Jacobson L.S., Clark I. The pathophysiology of canine babesiosis: new approaches to an old puzzle. J. S. Afr. Vet. Assoc. 1994, 65:134-145.
23. Welzl C., et al. Systemic inflammatory response syndrome and multiple-organ damage/dysfunction in complicated canine babesiosis. J. S. Afr. Vet. Assoc. 2001, 72:158-162.
24. Pagés J.P., et al. Description clinique, hématologique et serologique de 133 cas de babésiose canine. Pratique Médicale et Chirurgicale de l'Animal de Compagnie 1990, 25:89-97.
25. Taboada J., Merchant S.R. Babesiosis of companion animals and man. Vet. Clin. North Am. Small Anim. Pract. 1991, 21:103-123.
26. Adaszek L., et al. The clinical course of babesiosis in 76 dogs infected with protozoan parasites Babesia canis canis. Pol. J. Vet. Sci. 2009, 12:81-87.
27. Schetters T.P.M., et al. Systemic inflammatory responses in dogs experimentally infected with Babesia canis; a haematological study. Vet. Parasitol. 2009, 169:7-15.
28. Lobetti R.G. Canine babesiosis. Comp. Cont. Educ. Pract. Vet. 1998, 20:418-431.
29. Máthé A., et al. Clinical manifestations of canine babesiosis in Hungary (63 cases). Acta Vet. Hung. 2006, 54:367-385.
30. Matijatko V., et al. Systemic inflammatory response syndrome and multiple organ dysfunction syndrome in canine babesiosis. Vet. Arh. 2010, 80:611-626.
31. Torti M., et al. Komplizierte Verlaufsform der kaninen Babesiose: Fallbericht. Tierärztl. Umschau 2009, 64:139-146.
32. Matijatko V., et al. Septic shock in canine babesiosis. Vet. Parasitol. 2009, 162:263-270.
33. Furlanello T., et al. Clinicopathological findings in naturally occurring cases of babesiosis caused by large form Babesia from dogs of northeastern Italy. Vet. Parasitol. 2005, 134:77-85.
34. de Gopegui R.R., et al. Clinco-pathological findings and coagulation disorders in 45 cases of canine babesiosis in Spain. Vet. J. 2007, 174:129-132.
35. Camacho A.T., et al. Azotemia and mortality among Babesia microti-like infected dogs. J. Vet. Int. Med. 2004, 18:141-146.
36. De Waal D.T., Combrink M.P. Live vaccines against bovine babesiosis. Vet. Parasitol. 2006, 138:88-96.
37. Bock R.E., et al. Investigations of breakdowns in protection provided by living Babesia bovis vaccine. Vet. Parasitol. 1992, 43:45-56.
38. Carcy B., et al. Genetic basis for GPI-anchor merozoite surface antigen polymorphism of Babesia and resulting antigenic diversity. Vet. Parasitol. 2006, 138:33-49.
39. Schetters T.H., et al. Strain variation limits protective activity of vaccines based on soluble Babesia canis antigens. Par. Immunol. 1995, 17:215-218.
40. Schetters T., et al. Vaccination of dogs with soluble Babesia canis antigens derived from in vitro culture is strain-specific. Acta Parasitol. Turcica 1996, 20:543-550.
41. Florin-Christensen M., et al. The Babesia bovis merozoite surface antigen 2 locus contains four tandemly arranged and expressed genes encoding immunologically distinct proteins. Infect. Immun. 2002, 70:3566-3575.
42. Allred D.R., Al Khedery B. Antigenic variation of cytoadhesion in Babesia bovis and Plasmodium falciparum: different logics achieve the same goal. Mol. Biochem. Parasitol. 2004, 134:27-35.
43. Allred D.R., Al-Khedery B. Antigenic variation as an exploitable weakness of babesial parasites. Vet. Parasitol. 2006, 31:50-60.
44. Vercammen F., et al. Clinical and serological observations on experimental infections with Babesia canis and its diagnosis using IFAT. Parasite 1995, 2:407-410.
45. Brandão L.P., et al. Humoral immunity and reinfection resistance in dogs experimentally inoculated with Babesia canis and either treated or untreated with imidocarb dipropionate. Vet. Parasitol. 2003, 25:253-265.
46. Matijatko V., et al. Evidence of an acute phase response in dogs naturally infected with Babesia canis. Vet. Parasitol. 2007, 31:242-250.
47. Jacobson L.S. The South-African form of severe and complicated canine babesiosis: clinical advances 1994-2004. Vet. Parasitol. 2006, 138:126-139.
48. Rezaei S.A., Dalir-Naghadeh B. Evaluation of antioxidant status and oxidative stress in cattle naturally infected with Theileria annulata. Vet. Parasitol. 2006, 142:179-186.
49. Gutteridge J.M.C. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin. Chem. 1995, 41:1819-1828.
50. Halliwell B., Chirico S. Lipid peroxidation: its mechanism, measurement and significance. Am. J. Clin. Nutr. 1993, 57(Suppl.):715S-725S.
51. Rockett K.A., et al. Killing of Plasmodium falciparum in vitro by nitric oxide derivatives. Infect. Immun. 1991, 59:3280-3283.
52. Kiral F., et al. Dogs with Hepatozoon canis respond to the oxidative stress by increased production of glutathione and nitric oxide. Vet. Parasitol. 2005, 131:15-21.
53. Visser A.E., et al. Nitric oxide inhibits establishment of macroschizont-infected cell lines and is produced by macrophages of calves undergoing bovine tropical theileriosis or East Coast fever. Par. Immunol. 1995, 17:91-102.
54. Stich R.W., et al. Stimulation of nitric oxide production in macrophages by Babesia bovis. Infect. Immun. 1998, 66:4130-4136.
55. Müller S., et al. Thiol-based redox metabolism of protozoan parasites. Trends Parasitol. 2003, 19:320-328.
56. Crimi E., et al. Role of oxidative stress in experimental sepsis and multisystem organ dysfunction. Free Radic. Res. 2006, 40:665-672.
57. Moore K., Roberts L.J. Measurement of lipid peroxidation. Free Radic. Res. 1998, 28:659-671.
58. Crnogaj M., et al. Malondialdehyde levels in serum of dogs infected with Babesia canis. Vet. Med. Czech 2010, 55:163-171.
59. Maegraith B., et al. Pathological processes in Babesia canis infections. Z. Tropenmed. Parasit. 1957, 8:485-514.
60. Jacobson L.S., et al. Changes in haematocrit after treatment of uncomplicated canine babesiosis: a comparison between diminazene and trypan blue, and an evaluation of the infulence of parasitaemia. J. S. Afr. Vet. Assoc. 1996, 67:77-82.
61. Murase T., Maede Y. Increased erythrophagocytic activity of macrophages in dogs with Babesia gibsoni infection. Jpn. J. Vet. Sci. 1990, 52:321-327.
62. Jacobson L.S., Lobetti R.G. Glucose, lactate and pyruvate concentrations in dogs with babesiosis. Am. J. Vet. Res. 2005, 66:244-250.
63. Böhm M., et al. Capillary and venous Babesia canis rossi parasitemias and circulatory compromise. Vet. Parasitol. 2006, 141:18-29.
64. Köster L.S., et al. C-Reactive protein in canine babesiosis caused by Babesia rossi and its association with outcome. J. S. Afr. Vet. Assoc. 2009, 80:87-91.
65. Bone R.C., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. ACCP/SCCM Consensus Conference Committee. Chest 1992, 101:1644-1655.
66. Jacobson L.S., et al. Nitric oxide metabolites in naturally occurring canine babesiosis. Vet. Parasitol. 2002, 104:27-41.
67. Purvis D., Kirby R. Systemic inflammatory response syndrome: septic shock. Vet. Clin. North Am. Small Anim. Pract. 1994, 24:1225-1247.
68. Hauptmann J.G., et al. Evaluation of the sensitivity and specificity of diagnostic criteria for sepsis in dogs. Vet. Surg. 1997, 26:393-397.
69. Marshall J. Both the disposition and the means of cure: 'severe SIRS', 'sterile shock', and the ongoing challenge of description. Crit. Care Med. 1997, 25:1765-1766.
70. Vincent J.L. Dear SIRS, I'm sorry but I don't like you... Crit. Care Med. 1997, 25:372-374.
71. Brady C.A., Otto C.M. Systemic inflammatory response syndrome, sepsis, and multiple organ dysfunction. Vet. Clin. North Am. Small Anim. Pract. 2001, 31:1147-1162.
72. Okano S., et al. Usefulness of systemic inflammatory response syndrome criteria as an index for prognosis judgement. Vet. Rec. 2002, 150:245-246.
73. Bossink A.W., et al. Prediction of mortality in febrile medical patients: how useful are systemic inflammatory response syndrome and sepsis criteria?. Chest 1998, 113:1533-1541.
74. Houston D.M., Radostits O.M. The clinical examination. Veterinary Clinical Examination and Diagnosis 2000, 91-124. W.B. Saunders. O.M. Radostits (Ed.).
75. Schetters T.P.M., et al. Vaccination of dogs against Babesia canis infection using antigens from culture supernatants with emphasis on clinical babesiosis. Vet. Parasitol. 1994, 52:219-233.
76. Schetters T.P.M., et al. Different Babesia canis isolates, different diseases. Parasitology 1997, 115:485-493.
77. Reyers F., et al. Canine babesiosis in South Africa: more than one disease. Does this serve as a model for falciparum malaria?. Ann. Trop. Med. Parasitol. 1998, 92:503-511.
78. Bourdeau P., Guelfi J.F. La babésiose canine à Babesia canis. Point Vét. 1995, 27:103-116.
79. Wlosniewski A., et al. Etude du portage asymptomatique de Babesia canis en zone d'enzootie. Comp. Immun. Microbiol. Infect. Dis. 1997, 20:75-86.
80. Martinod S., et al. Resistance and immunity of dogs against Babesia canis in an endemic area. Vet. Parasitol. 1986, 19:245-254.
81. Matjila P.T. Preliminary evaluation of the BrEMA1 gene as a tool for associating Babesia rossi genotypes and clinical manifestation of canine babesiosis. J. Clin. Microbiol. 2009, 47:3586-3592.
82. Udwadia F.E. Multiple organ dysfunction syndrome due to tropical infections. Ind. J. Crit. Care Med. 2003, 7:233-236.
83. Nyström P.O. The systemic inflammatory response syndrome: definitions and aetiology. J. Antimicrob. Chemother. 1998, 41(Suppl. A):1-7.
84. Shaio M.F., Lin P.R. A case study of cytokine profiles in acute human babesiosis. Am. J. Trop. Med. Hyg. 1998, 58:335-337.
85. Shoda L.K., et al. Babesia bovis-stimulated macrophages express interleukin-1beta, interleukin-12, tumor necrosis factor alpha, and nitric oxide and inhibit parasite replication in vitro. Infect. Immun. 2000, 68:5139-5145.
86. Hanafusa Y., et al. Pathogenesis of Babesia caballi infection in experimental horses. J. Vet. Med. Sci. 1998, 60:1127-1132.
87. Zahler M., et al. Babesia gibsoni of dogs from North America and Asia belong to different species. Parasitology 2000, 120:365-369.
88. Camacho A.T., et al. Ixodes hexagonus is the main candidate as vector of Theileria annae in northwest Spain. Vet. Parasitol. 2003, 112:157-163.
89. Criado-Fornelio A., et al. Molecular characterization of a Babesia gibsoni isolate from a Spanish dog. Vet. Parasitol. 2003, 117:123-129.
90. Kjemtrup A.M., et al. Babesia conradae sp. nov., small canine Babesia identified in California. Vet. Parasitol. 2006, 138:103-111.
91. Boozer A.L., Macintire D.K. Canine babesiosis. Vet. Clin. North Am. Small Anim. Pract. 2003, 33:885-904.
92. Matjila P.T., et al. Confirmation of occurrence of Babesia canis vogeli in domestic dogs in South Africa. Vet. Parasitol. 2004, 122:119-125.
93. Gülanber A., et al. First molecular diagnosis of Babesia vogeli in domestic dogs from Turkey. Vet. Parasitol. 2006, 139:224-230.
94. Inokuma H., et al. Molecular survey of Babesia infection in dogs in Okinawa, Japan. Vet. Parasitol. 2004, 121:341-346.
95. Jefferies R., et al. Two species of canine Babesia in Australia: detection and characterization by PCR. J. Parasitol. 2003, 89:409-412.
96. Birkenheuer A.J., et al. Development and evaluation of a semi-nested PCR for detection and differentiation of Babesia gibsoni (Asian genotype) and Babesia canis in canine blood samples. J. Clin. Microbiol. 2003, 41:4172-4177.
97. Passos L.M.F., et al. First molecular detection of Babesia vogeli in dogs from Brazil. Vet. Parasitol. 2003, 121:81-85.
98. Birkenheuer A.J., et al. Babesia gibsoni infections in dogs from North Carolina. J. Am. Anim. Hosp. Assoc. 1999, 25:125-128.
99. Muhlnickel C.J., et al. Babesia gibsoni infection in three dogs in Victoria. Aust. Vet. J. 2002, 80:606-610.
100. Zahler M., et al. Detection of a new pathogenic Babesia microti-like species in dogs. Vet. Parasitol. 2000, 89:241-248.